Sublingual immunotherapy for pediatric allergic rhinitis

The clinical evidence

Dimitri Poddighe, Amelia Licari, Silvia Caimmi, Gian Luigi Marseglia

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Allergic rhinitis is estimated to affect 10%-20% of pediatric population and it is caused by the IgE-sensitization to environmental allergens, most importantly grass pollens and house dust mites. Allergic rhinitis can influence patient's daily activity severely and may precede the development of asthma, especially if it is not diagnosed and treated correctly. In addition to subcutaneous immunotherapy, sublingual immunotherapy (SLIT) represents the only treatment being potentially able to cure allergic respiratory diseases, by modulating the immune system activity. This review clearly summarizes and analyzes the available randomized, double-blinded, placebo-controlled trials, which aimed at evaluating the effectiveness and the safety of grass pollen and house dust mite SLIT for the specific treatment of pediatric allergic rhinitis. Our analysis demonstrates the good evidence supporting the efficacy of SLIT for allergic rhinitis to grass pollens in children, whereas trials regarding pediatric allergic rhinitis to house dust mites present lower quality, although several studies supported its usefulness.

Original languageEnglish
Pages (from-to)47-56
Number of pages10
JournalWorld journal of clinical pediatrics
Volume5
Issue number1
DOIs
Publication statusPublished - Feb 8 2016
Externally publishedYes

Fingerprint

Sublingual Immunotherapy
Pyroglyphidae
Pediatrics
Pollen
Poaceae
Immune System Diseases
Immunotherapy
Allergens
Immunoglobulin E
Asthma
Placebos
Allergic Rhinitis
Safety
Therapeutics
Population

Cite this

Sublingual immunotherapy for pediatric allergic rhinitis : The clinical evidence. / Poddighe, Dimitri; Licari, Amelia; Caimmi, Silvia; Marseglia, Gian Luigi.

In: World journal of clinical pediatrics, Vol. 5, No. 1, 08.02.2016, p. 47-56.

Research output: Contribution to journalReview article

Poddighe, Dimitri ; Licari, Amelia ; Caimmi, Silvia ; Marseglia, Gian Luigi. / Sublingual immunotherapy for pediatric allergic rhinitis : The clinical evidence. In: World journal of clinical pediatrics. 2016 ; Vol. 5, No. 1. pp. 47-56.
@article{26c7eb351ab34830927a41ed32ea8346,
title = "Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence",
abstract = "Allergic rhinitis is estimated to affect 10{\%}-20{\%} of pediatric population and it is caused by the IgE-sensitization to environmental allergens, most importantly grass pollens and house dust mites. Allergic rhinitis can influence patient's daily activity severely and may precede the development of asthma, especially if it is not diagnosed and treated correctly. In addition to subcutaneous immunotherapy, sublingual immunotherapy (SLIT) represents the only treatment being potentially able to cure allergic respiratory diseases, by modulating the immune system activity. This review clearly summarizes and analyzes the available randomized, double-blinded, placebo-controlled trials, which aimed at evaluating the effectiveness and the safety of grass pollen and house dust mite SLIT for the specific treatment of pediatric allergic rhinitis. Our analysis demonstrates the good evidence supporting the efficacy of SLIT for allergic rhinitis to grass pollens in children, whereas trials regarding pediatric allergic rhinitis to house dust mites present lower quality, although several studies supported its usefulness.",
author = "Dimitri Poddighe and Amelia Licari and Silvia Caimmi and Marseglia, {Gian Luigi}",
year = "2016",
month = "2",
day = "8",
doi = "10.5409/wjcp.v5.i1.47",
language = "English",
volume = "5",
pages = "47--56",
journal = "World journal of clinical pediatrics",
issn = "2219-2808",
number = "1",

}

TY - JOUR

T1 - Sublingual immunotherapy for pediatric allergic rhinitis

T2 - The clinical evidence

AU - Poddighe, Dimitri

AU - Licari, Amelia

AU - Caimmi, Silvia

AU - Marseglia, Gian Luigi

PY - 2016/2/8

Y1 - 2016/2/8

N2 - Allergic rhinitis is estimated to affect 10%-20% of pediatric population and it is caused by the IgE-sensitization to environmental allergens, most importantly grass pollens and house dust mites. Allergic rhinitis can influence patient's daily activity severely and may precede the development of asthma, especially if it is not diagnosed and treated correctly. In addition to subcutaneous immunotherapy, sublingual immunotherapy (SLIT) represents the only treatment being potentially able to cure allergic respiratory diseases, by modulating the immune system activity. This review clearly summarizes and analyzes the available randomized, double-blinded, placebo-controlled trials, which aimed at evaluating the effectiveness and the safety of grass pollen and house dust mite SLIT for the specific treatment of pediatric allergic rhinitis. Our analysis demonstrates the good evidence supporting the efficacy of SLIT for allergic rhinitis to grass pollens in children, whereas trials regarding pediatric allergic rhinitis to house dust mites present lower quality, although several studies supported its usefulness.

AB - Allergic rhinitis is estimated to affect 10%-20% of pediatric population and it is caused by the IgE-sensitization to environmental allergens, most importantly grass pollens and house dust mites. Allergic rhinitis can influence patient's daily activity severely and may precede the development of asthma, especially if it is not diagnosed and treated correctly. In addition to subcutaneous immunotherapy, sublingual immunotherapy (SLIT) represents the only treatment being potentially able to cure allergic respiratory diseases, by modulating the immune system activity. This review clearly summarizes and analyzes the available randomized, double-blinded, placebo-controlled trials, which aimed at evaluating the effectiveness and the safety of grass pollen and house dust mite SLIT for the specific treatment of pediatric allergic rhinitis. Our analysis demonstrates the good evidence supporting the efficacy of SLIT for allergic rhinitis to grass pollens in children, whereas trials regarding pediatric allergic rhinitis to house dust mites present lower quality, although several studies supported its usefulness.

U2 - 10.5409/wjcp.v5.i1.47

DO - 10.5409/wjcp.v5.i1.47

M3 - Review article

VL - 5

SP - 47

EP - 56

JO - World journal of clinical pediatrics

JF - World journal of clinical pediatrics

SN - 2219-2808

IS - 1

ER -